Topic 3: OUD Treatment in Specific Settings

Prior to the development of FDA approved medications for Opioid Use Disorder, twelve step programs provided one of the only options for managing opioid use disorder. As the prevalence of Opioid use disorder and opioid related deaths has increased, so has the need for treatment that addresses the biopsychosocial aspects of the disease.

Patients with OUD taking evidence-based...

Faculty

• Danielle Anderson , MD
• Nick Kimberlain

Prior to the development of FDA approved medications for Opioid Use Disorder, twelve step programs provided one of the only options for managing opioid use disorder. As the prevalence of Opioid use disorder and opioid related deaths has increased, so has the need for treatment that addresses the biopsychosocial aspects of the disease.

Patients with OUD taking evidence-based...

Faculty

• Danielle Anderson , MD
• Nick Kimberlain

Syringe Services Programs (SSP’s), also called Syringe Exchange Programs (SEP’s), are a key component of a comprehensive strategy to address the opioid, HIV and Hepatitis C epidemics, providing public health services to a highly vulnerable population.  Despite the benefits that SSP’s/SEP’s provide there is a lack of understanding of the services and...

Faculty

• Jana D. Collins , MS
• Chase Barnes , MPH

Faculty

• Margaret McGladrey , PhD
• Susannah Stitzer , JD

Faculty

• Margaret McGladrey , PhD
• Susannah Stitzer , JD

Faculty

• Paxton Bach , MD, MSc, ABIM, FRCPC, FASAM

Pharmacy-based care normalizes receipt of medication for opioid use disorder (MOUD), which may increase treatment engagement and reduce stigma and overdose risk.  Most states allow pharmacists to collaborate with prescribers, confer prescriptive authority, or have other mechanisms to expand the scope of practice for...

Faculty

• Traci Green , PhD, MSc